Elan Penn - 18 Mar 2026 Form 3 Insider Report for CollPlant Biotechnologies Ltd (CLGN)

Role: Director
Signature: /s/ Elan Penn
Issuer symbol: CLGN
Transactions as of: 18 Mar 2026
Net transactions value: $0
Form type: 3
Filing time: 18 Mar 2026, 10:20:54 UTC
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
Penn Elan	Director	C/O COLLPLANT BIOTECHNOLOGIES LTD., 4 OPPENHEIMER ST, WEIZMANN SCIENCE PARK, REHOVOT, ISRAEL	/s/ Elan Penn	18 Mar 2026	0001423293

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	CLGN	Restricted Share Units						7,500	18 Mar 2026	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	CLGN	Options to Purchase Ordinary Shares							18 Mar 2026	Ordinary Shares	10,000	$4.02	Direct	F2
holding	CLGN	Options to Purchase Ordinary Shares							18 Mar 2026	Ordinary Shares	8,000	$6.39	Direct	F2
holding	CLGN	Options to Purchase Ordinary Shares							18 Mar 2026	Ordinary Shares	24,000	$6.39	Direct	F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Of the restricted share units reported herein, 625 units are vested, and the remaining 6,875 units vest in eleven equal quarterly installments beginning March 25, 2026 and ending September 25, 2028, subject to the Reporting Person's continued service to the Issuer as of such vesting date.
F2	Fully vested and exercisable.
F3	22,500 options are fully vested and exercisable and the remaining 1,500 vest is May 2, 2026, subject to the Reporting Person's continued service to the Issuer as of such vesting date.